We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+2.95%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$193B
AUM Growth
+$9.98B
Cap. Flow
+$5.76B
Cap. Flow %
2.98%
Top 10 Hldgs %
13.3%
Holding
8,497
New
756
Increased
3,610
Reduced
2,944
Closed
742

Sector Composition

Rank Sector Weight
1 Financials 7.75%
2 Healthcare 6.75%
3 Technology 6.26%
4 Industrials 5.06%
5 Consumer Discretionary 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PGM
7376
DELISTED
iPath Bloomberg Platinum Subindex Total Return ETN due June 24, 2038
PGM
$2K ﹤0.01%
100
PACD
7377
DELISTED
Pacific Drilling S A
PACD
$2K ﹤0.01%
970
+917
+1,730% +$1.68K
ASET
7378
DELISTED
FlexShares Real Assets Allocation Index Fund
ASET
$1K ﹤0.01%
+20
New +$544
ATHE
7379
Alterity Therapeutics
ATHE
$82.7M
$1K ﹤0.01%
38
-320
-89% -$7.96K
BBC icon
7380
Virtus Biotech Clinical Trials ETF
BBC
$46M
$1K ﹤0.01%
36
-893
-96% -$20K
BYSI icon
7381
BeyondSpring
BYSI
$47.3M
$1K ﹤0.01%
23
-2,789
-99% -$82.8K
CDNA icon
7382
CareDx
CDNA
$1.83B
$1K ﹤0.01%
1,000
CDTX
7383
DELISTED
Cidara Therapeutics
CDTX
$1K ﹤0.01%
7
-59
-89% -$8.15K
CIG.C icon
7384
CEMIG Ordinary Shares
CIG.C
$9.11B
$1K ﹤0.01%
747
-1,859
-71% -$3.1K
COHN icon
7385
Cohen & Co
COHN
$33.8M
$1K ﹤0.01%
+116
New +$1.38K
CRD.A icon
7386
Crawford & Co Class A
CRD.A
$542M
$1K ﹤0.01%
96
CROX icon
7387
Crocs
CROX
$6.63B
$1K ﹤0.01%
74
-3,407
-98% -$22.9K
CVM icon
7388
CEL-SCI Corp
CVM
$19.9M
$1K ﹤0.01%
10
-176
-95% -$12.3K
BGMS
7389
Bio Green Med Solution Inc
BGMS
$4.86M
0
DHX icon
7390
DHI Group
DHX
$177M
$1K ﹤0.01%
202
DNN icon
7391
Denison Mines
DNN
$2.43B
$1K ﹤0.01%
1,993
-38,821
-95% -$19.7K
DUSA icon
7392
Davis Select US Equity ETF
DUSA
$1.26B
$1K ﹤0.01%
+30
New +$619
DWSN icon
7393
Dawson Geophysical
DWSN
$130M
$1K ﹤0.01%
229
-503
-69% -$2.2K
DXLG icon
7394
Destination XL Group
DXLG
$32.9M
$1K ﹤0.01%
392
-2,150
-85% -$5.27K
ELTK icon
7395
Eltek
ELTK
$58.2M
$1K ﹤0.01%
220
-300
-58% -$971
FDVV icon
7396
Fidelity High Dividend ETF
FDVV
$10.1B
$1K ﹤0.01%
+24
New +$642
GBR icon
7397
New Concept Energy
GBR
$3.5M
$1K ﹤0.01%
426
-1,526
-78% -$2.44K
HCKT icon
7398
Hackett Group
HCKT
$281M
$1K ﹤0.01%
34
-6,415
-99% -$109K
HSCZ icon
7399
iShares Currency Hedged MSCI EAFE Small-Cap ETF
HSCZ
$238M
$1K ﹤0.01%
+33
New +$929
IDT icon
7400
IDT Corp
IDT
$1.67B
$1K ﹤0.01%
78
-2,501
-97% -$32.4K

Similar funds

UBS Group's Q2 2017 Portfolio in Review

As of Q2 2017, UBS Group held 8,497 positions worth $193B, up 5.4% from $183B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q2 2017 filing shows 756 new, 3,610 increased, 2,944 reduced and 742 closed positions. Its largest new stake was Ultra Petroleum Corp. Common Stock: 3,128,785 shares worth $33.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $3.06B.

By sector, the portfolio is most concentrated in Financials at 7.7% of assets, up from 7.4% a quarter earlier, followed by Healthcare and Technology.

  • UBS Group's largest Q2 2017 buy was Ultra Petroleum Corp. Common Stock: 3,128,785 shares worth $33.9M.
  • UBS Group added most to Monsanto Co in Q2 2017, an estimated $622M increase.
  • UBS Group's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.06B.
  • UBS Group fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $383M.
  • UBS Group's ten largest holdings make up 13% of its $193B portfolio in Q2 2017.
  • UBS Group opened 756 new positions and closed 742 in Q2 2017.
  • UBS Group's portfolio value rose 5.4% quarter-over-quarter to $193B.

Based on UBS Group's 13F filing for Q2 2017, filed 14 Aug 2017.